AmerisourceBergen (ABC) Reaffirms FY09 EPS Outlook
More News related to ABC
- AmeriSourceBergen (ABC) Beats Q4 Views by 4c; Guides FY10
- AmerisourceBergen Reports $0.44 Diluted EPS, Up 22 Percent, and Record Revenue, Up 9 Percent, in the September Quarter
- Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
- BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
- AmerisourceBergen Announces Date and Time for Fourth Quarter and Fiscal Year End Earnings Release
More News related to Guidance
- Toll (TOL) Reports Preliminary Q4, FY09 Results
- China Digital TV (STV) Misses Q3 EPS by 2c; Guides Below for Q4
- AirMedia Group (AMCN) Tops Q3 EPS by 3c; Guides In-line for Q4
- Maidenform Brands (MFB) Reports Mixed Q3 Earnings; Guides Q4, Raises FY09 Outlook
- Emdeon (EM) Tops Q3 EPS by 2c; Guides In-line for FY09
AmerisourceBergen Corporation (NYSE: ABC) today will reaffirm its previous fiscal year 2009 guidance at its Investor Day Meeting in New York City.
Sees FY09 EPS of $3.08-$3.25, versus the Street estimate of $3.14. Sees sales growth of 1%-3%, reflecting expected market conditions, customer mix, and the 3 percent negative impact from the loss on July 1, 2008 of a large retail drug chain; operating margin expansion in the low to mid single digit basis point range; and free cash flow in the range of $460-$535 million, which includes capital expenditures in the $140 million range.
AmerisourceBergen Corporation, a pharmaceutical services company, offers drug distribution and related services to healthcare providers and pharmaceutical manufacturers in the United States, the United Kingdom, and Canada.
Related Categories
GuidanceStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
